Common antibiotic can have serious adverse reactions
trimethoprim-sulfamethoxazole that has been used since 1968 can cause serious adverse reactions and physicians need to be aware of these in prescribing, states a review in CMAJ (Canadian Medical...
View ArticleScientists discover how to design drugs that could target particular nerve cells
(Medical Xpress) -- The future of drug design lies in developing therapies that can target specific cellular processes without causing adverse reactions in other areas of the nervous system. Scientists...
View ArticleAustralia experts call for energy drink warnings
Researchers in Australia on Monday called for health warnings on caffeine-loaded energy drinks following a spike in the number of people reporting medical problems after drinking them.
View ArticleAdministration of meningococcal vaccine with other routine infant vaccines...
Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against...
View ArticleArchive of failed joint replacements provides tips to building a better hip...
A study by Hospital for Special Surgery researchers has provided the first comprehensive look at just how metal-on-metal total hip replacements are failing in patients around the country. Made possible...
View ArticleKids' penicillin allergy may not signal other drug reactions
(HealthDay) -- Children who are allergic to penicillin are not more likely than other kids to develop additional drug allergies, new research suggests.
View ArticleNew research could significantly reduce the need for clinical animal testing
University of Southampton researchers are investigating innovative methods of testing drugs that will reduce the need for involving animals.
View ArticlePrescribing opioids for pain after short-stay surgery appears associated with...
Prescribing opioids for pain to older patients within seven days of short-stay surgery appears to be associated with long-term analgesic use compared to those patients who did not receive prescriptions...
View ArticleInternet and new drugs: A challenge for public health
A group of researchers from the IMIM (Hospital del Mar Research Institute) and from the INAD (Hospital del Mar Neuropsychiatry and Addictions Institute) has participated in an international study...
View ArticleChanges needed for oft-ignored prescription warning labels
Each year, an estimated four million Americans experience adverse reactions to prescription medications. Many of these reactions, ranging from mild rashes and drowsiness to hospitalization and death,...
View ArticleRoche probed over faulty drug-safety reporting
Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.
View ArticleKyprolis approved for multiple myeloma
(HealthDay) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.
View ArticleStudy shows efficacy of new rheumatoid arthritis drug
(Medical Xpress) -- A new study involving researchers from Karolinska Institutet demonstrates the efficacy of Tofacitinib, a new drug for rheumatoid arthritis. According to the study, which is...
View ArticleEvaluate children's stress after natural disasters
As Hurricane Isaac nears the Gulf Coast, one may wonder what the impact of natural disasters are on children. Who is most at risk for persistent stress reactions? How can such youth be identified and...
View ArticleAubagio approved for multiple sclerosis
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
View ArticleHopes that new substance will induce cancer cell suicide
(Medical Xpress)—The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective,...
View ArticleCalls for more US oversight after tainted drug outbreak
A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.
View ArticleAbraxane approved to treat advanced lung cancer
(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung...
View ArticleXeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by,...
View ArticleSignifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
View Article